TITLE:
Reintervention with Transcatheter and Surgical Aortic Valves: A Systematic Review and Meta-Analysis
AUTHORS:
Kevin G. Buda, Michael S. Megaly, Vinayak N. Bapat, Robert Steffen, João L. Cavalcante, Santiago Garcia
KEYWORDS:
TAVR, SAVR, Structural Valve Deterioration, Bioprosthetic Valve Failure, Durability, Meta-Analysis
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.11 No.5,
May
28,
2021
ABSTRACT: Background: Despite expanding indications, data regarding the long-term durability of transcatheter heart valves (THV) are limited. Methods: We performed a systematic review and meta-analysis of all published studies with ≥5years of follow-up reporting aortic valve reintervention rates of transcatheter (TAVR) and surgical aortic valve replacement (SAVR). Randomized controlled trials (n = 4) and propensity-matched observational studies (n = 1) involving all surgical risk categories were included.The primary endpoint was the composite of aortic valve reintervention and death. Results: Themeta- analysis included 4145 patients: 2101 underwent TAVR (mean age 81.7 ± 6.7 years, 54% male) and 2044 SAVR (mean age 81.8 ± 6.6 years, 54% male). All TAVR procedures were performed with early generations of THV. At a median follow-up of 5 years (range 5 - 6 years), TAVR had higher reintervention rates (odds ratio (OR) 3.33; 95% CI: [1.78, 6.24], p 2 = 0%), all-cause mortality (OR 1.45; 95% CI: [1.22, 1.75], p 2 = 44%) and the composite of reintervention and death (OR 1.47; 95% CI: [1.14, 1.91], p 2 = 64%). Rates of myocardial infarction, transient ischemic attack, stroke, endocarditis, and the composite of endocarditis and thrombosis were similar between the groups. Conclusion: Despite comparable short and medium-term results, TAVR with early-generation THV has higher rates of reintervention and the composite of reintervention and death. Further studies employing newer definitions of structural valve deterioration and bioprosthetic valve failure are needed to assess whether technological enhancements in THV technology will improve long-term outcomes.